~~<i id='AB1F34E15B'><strike id='AB1F34E15B'><tt id='AB1F34E15B'><pre id='AB1F34E15B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：entertainment 2025-09-28 00:52:14 - browse：478

An illustration of red blood cells — Adobe

As a boy growing up with hemophilia A, Noah Frederick reserved the end of his annual checkups to talk about new technologies. His doctor walked through various experimental approaches for the bleeding disorder and, invariably, gene therapy. It was coming, he always said, in your lifetime.

Last year, it finally arrived. But Frederick, now a 23-year-old software engineer, isn’t sure he’ll get it. He wants to be part of the sci-fi future gene therapy has always represented, but a recent doctor’s visit left him uncertain.

“I’m on the fence,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

focus

explore

knowledge

hotspot

leisure time

Themedicalcommunitytodayfacesadeceptivelysimplequestion:Howquicklyshouldweactwhenachild’slifeisonthe

WSS

What to do when lifesaving products contribute to climate change

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

FDA's Pazdur wants cancer trials to range beyond China alone

Flagship Pioneering launches a new biotech in two countries

See how much Covid

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

focus

hotspot

focus

Medical records are filled with copy

Ultragenyx gene therapy for rare liver ailment succeeds in late

United colonoscopy coverage change 'may cost lives,' doctors say

Will the market for weight loss drugs really reach $100 billion?

23andMe had bad news about my health. I wish a person had delivered it

U.K. Biobank has 500,000 peoples' genome sequences available

Medical records are filled with copy

Woman returns to dialysis after doctors remove transplanted pig kidney

Jerome Adams on the need for new antivirals for Covid

UnitedHealth’s Optum accused of antitrust violations in California

explore

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

30 years of 'Listening to Prozac'

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

The EPA's new lead rule: How one expert crunched the numbers

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

knowledge

hotspot

hotspot

leisure time